Bradley C. s/ Bradley C. s/ Bradley C.

Microsoft PowerPoint - Avient Q4 Earnings and 2021 Outlook PRINT AVIENT CORPORATION F O U R T H Q U A R T E R 2 0 2 0 R E S U L T S A N D 2 0 2 1 F I N A N C I A L G U I D A N C E (NYSE: AVNT) F E B R U A R Y 9 , 2 0 2 1 DISCLAIMER Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.

c. Contact Avient’s Legal Department at your first opportunity and document the incident. 9 North America Global Headquarters Avon Lake, United States 33587 Walker Road Avon Lake, OH, United States 44012 Toll Free: +1 866 765 9663 Phone: +1 440 930 1000 Fax: +440 930 3064 Asia Pacific Regional Headquarters Shanghai, China 2F, Block C 200 Jinsu Road Pudong, 201206 Shanghai, China Telephone: +86 (0) 21 6028 4888 Fax: +86 (0) 21 6028 4999 South America Sao Paulo, Brazil Av.

& Canada 51% Latin America 2021 YTD SEGMENT, END MARKET AND GEOGRAPHY 38 GEOGRAPHY REVENUESEGMENT FINANCIALS 23% 19% Building and END MARKET REVENUE (1) Total company sales and EBITDA of $3,617M and $455M, respectively, include intercompany sales eliminations and corporate costs All charts reflect YTD financials through September 30 $1,820M $321M $691M $127M $1,206M $72M Sales Adjusted EBITDA Distribution Specialty Engineered Materials Color Additives and Inks $455M$3,617M 34% 21% 7% Building & 9% 2% Telecommunications C O L O R , A D D I T I V E S & I N K S 2021 YTD REVENUE | $1 .8 BILL ION 31% 42% 21% Latin America END MARKET REGION 39 S P E C I A LT Y E N G I N E E R E D M AT E R I A L S 28% 11% Building & 7% 2021 YTD REVENUE | $691 MILLION END MARKET 55% 20% REGION 40 DI S TR IBU T I ON 26% 22% 20% Building and 81% Latin America END MARKET REGION K E Y S U P P L I ER S 2021 YTD REVENUE | $1 .2 BILL ION 41 TOTA L C O M PA N Y R E G I O N A L S A L E S BY END MARKET 30% 27% Building & 2% Energy (16% of sales) 31% 17% Building & (25% of sales) 42 19% 17% Building & US & Canada (51% of sales) 13% 42% 33% 3% Building & LATAM (8% of sales) Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) 2021年9月30日 Reconciliation to Condensed Consolidated Statements of Income GAAP Special Adjusted Operating income $ 78.7 $ 20.0 $ 98.7 Income from continuing operations before income taxes $ 61.1 $ 19.9 $ 81.0 Income tax expense - GAAP (8.5) — (8.5) Income tax impact of special items — (4.6) (4.6) Tax adjustments — (3.6) (3.6) Net income attributable to noncontrolling interests 0.3 — 0.3 Net income from continuing operations attributable to Avient shareholders $ 52.9 $ 11.7 $ 64.6 Net income / EPS $ 0.57 $ 0.13 $ 0.70 Weighted-average diluted shares 92.2 92.2 92.2 2020年9月30日 Reconciliation to Condensed Consolidated Statements of Income GAAP Special Adjusted Operating income $ 33.5 $ 40.4 $ 73.9 Income from continuing operations before income taxes $ 5.3 $ 50.0 $ 55.3 Income tax expense - GAAP (2.7) — (2.7) Income tax impact of special items — (12.7) (12.7) Tax adjustments — 3.0 3.0 Net income attributable to noncontrolling interests (0.9) — (0.9) Net income from continuing operations attributable to Avient shareholders $ 1.7 $ 40.3 $ 42.0 Net income / EPS $ 0.02 $ 0.44 $ 0.46 Weighted-average diluted shares 91.9 91.9 91.9 Three Months Ended Three Months Nine Months Year Ended December 31, Reconciliation to Pro Forma Adjusted EBITDA 2021 2020 2021年6月30日 2021年9月30日 2020 2019 2018 Net income from continuing operations – GAAP $ 52.6 $ 2.6 $ 69.4 $ 201.7 $ 133.8 $ 75.7 $ 87.4 Income tax expense 8.5 2.7 20.4 51.8 5.2 33.7 14.4 Interest expense 19.0 29.7 19.5 57.8 74.6 59.5 62.8 Debt extinguishment cost — — — — — — 1.1 Depreciation and amortization from continuing operations 36.8 36.5 33.8 107.7 115.0 78.1 72.6 EBITDA $ 116.9 71.5 $ 143.1 $ 419.0 $ 328.6 $ 247.0 $ 238.3 Special items, before tax 19.9 50.0 14.2 36.5 66.2 61.7 59.5 Interest expense included in special items — (9.6) — — (10.1) — — Depreciation and amortization included in special items (0.9) (1.3) 1.4 (0.1) (3.2) — (3.0) Adjusted EBITDA $ 135.9 $ 110.6 $ 158.7 $ 455.4 $ 381.6 $ 308.7 $ 294.8 Clariant MB pro forma adjustments(1) — — — — 75.1 133.2 141.5 Pro forma adjusted EBITDA $ 135.9 $ 110.6 $ 158.7 $ 455.4 $ 456.7 $ 441.9 $ 436.3 (1) Pro forma adjustments for the periods prior to the acquisition date (2020年7月1日) and to give effects to the financing for the acquisition Reconciliation of EBITDA by Segment Nine Months 2021年12月31日 2020 2021 2020 2019 2018 Sales: Color, Additives and Inks $ 586.6 $ 493.8 $ 1,820.3 $ 1,502.9 $ 1,003.8 $ 1,046.5 Specialty Engineered Materials 233.6 174.1 690.7 708.8 745.7 645.8 Distribution 438.8 276.9 1,205.9 1,110.3 1,192.2 1,265.4 Corporate and eliminations (39.2) (20.3) (99.6) (79.9) (79.0) (76.7) Sales $ 1,219.8 $ 924.5 $ 3,617.3 $ 3,242.1 $ 2,862.7 $ 2,881.0 Operating income: Color, Additives and Inks $ 66.8 $ 50.5 $ 241.9 $ 180.8 $ 147.4 $ 158.5 Specialty Engineered Materials 31.7 24.7 103.2 94.4 83.7 72.3 Distribution 23.8 17.5 71.5 69.5 75.4 71.5 Corporate and eliminations (43.6) (59.2) (109.4) (155.4) (149.7) (123.7) Operating income $ 78.7 $ 33.5 $ 307.2 $ 189.3 $ 156.8 $ 178.6 Items below OI in Corporate: Other income, net $ 1.4 $ 1.5 $ 4.1 $ 24.3 $ 12.1 $ (12.9) Depreciation & amortization: Color, Additives and Inks $ 26.6 $ 26.3 $ 79.2 $ 75.1 $ 42.7 $ 44.3 Specialty Engineered Materials 7.9 7.5 23.8 30.0 29.5 23.2 Distribution 0.2 0.2 0.6 0.7 0.5 0.7 Corporate and eliminations 2.1 2.5 4.1 9.2 5.4 4.4 Depreciation & Amortization $ 36.8 $ 36.5 $ 107.7 $ 115.0 $ 78.1 $ 72.6 EBITDA: Color, Additives and Inks $ 93.4 $ 76.8 $ 321.1 $ 255.9 $ 190.1 $ 202.8 Specialty Engineered Materials 39.6 32.2 127.0 124.4 113.2 95.5 Distribution 24.0 17.7 72.1 70.2 75.9 72.2 Corporate and eliminations (41.5) (56.7) (105.3) (146.2) (144.3) (119.3) EBITDA $ 116.9 $ 71.5 $ 419.0 $ 328.6 $ 247.0 $ 238.3 EBITDA as a % of Sales: Color, Additives and Inks 15.9 % 15.6 % 17.6 % 17.0 % 18.9 % 19.4 % Specialty Engineered Materials 17.0 % 18.5 % 18.4 % 17.6 % 15.2 % 14.8 % Distribution 5.5 % 6.4 % 6.0 % 6.3 % 6.4 % 5.7 % Reconciliation of Pro Forma EBITDA - Color, Additives and Inks Year Ended 2020年12月31日 2019 2018 Sales: Color, Additives and Inks $ 1,502.9 $ 1,003.8 $ 1,046.5 Clariant MB pro forma adjustments(1) 540.4 1,118.6 1,209.8 Pro forma sales $ 2,043.3 $ 2,122.4 $ 2,256.3 Operating income: Color, Additives and Inks $ 180.8 $ 147.4 $ 158.5 Clariant MB pro forma adjustments(1) 45.0 72.9 80.3 Pro forma operating income $ 225.8 $ 220.3 $ 238.8 Depreciation & amortization: Color, Additives and Inks $ 75.1 $ 42.7 $ 44.3 Clariant MB pro forma adjustments(1) 30.1 60.3 61.2 Pro forma depreciation & amortization $ 105.2 $ 103.0 $ 105.5 EBITDA Color, Additives and Inks $ 255.9 $ 190.1 $ 202.8 Clariant MB pro forma adjustments(1) 75.1 133.2 141.5 Pro forma EBITDA $ 331.0 $ 323.3 $ 344.3 Pro forma EBITDA as a % of Sales 16.2 % 15.2 % 15.3 % 2020年12月31日 Reconciliation of Pro Forma Adjusted Earnings per Share Avient Special Adjusted Clariant MB Pro Forma Adjustments(1) Pro Forma Adjusted Sales $ 3,242.1 $ — $ 3,242.1 $ 540.4 $ 3,782.5 Operating income $ 189.3 $ 73.7 $ 263.0 $ 45.0 $ 308.0 Interest expense, net (74.6) 10.1 (64.5) (18.1) (82.6) Other income, net 24.3 (17.6) 6.7 — 6.7 Income taxes (5.2) (41.4) (46.6) (6.2) (52.8) Net income attributable to noncontrolling interests (1.8) — (1.8) — (1.8) Net income from continuing operations attributable to Avient shareholders $ 132.0 $ 24.8 $ 156.8 $ 20.7 $ 177.5 Weighted average diluted shares 90.6 Impact to diluted shares from January 2020 equity offering 1.5 Pro forma weighted average diluted shares 92.1 Pro forma adjusted EPS $ 1.93 2019年12月31日 Reconciliation of Pro Forma Adjusted Earnings per Share Avient Special Adjusted Clariant MB Pro Forma Adjustments(1) Pro Forma Adjusted Sales $ 2,862.7 $ — $ 2,862.7 $ 1,118.6 $ 3,981.3 Operating income $ 156.8 $ 71.7 $ 228.5 $ 72.9 $ 301.4 Interest expense, net (59.5) — (59.5) (33.4) (92.9) Other income, net 12.1 (10.0) 2.1 — 2.1 Income taxes (33.7) (5.9) (39.6) (9.1) (48.7) Net income attributable to noncontrolling interests (0.2) — (0.2) — (0.2) Net income from continuing operations attributable to Avient shareholders $ 75.5 $ 55.8 $ 131.3 $ 30.4 $ 161.7 Weighted average diluted shares 77.7 Impact to diluted shares from January 2020 equity offering 15.3 Pro forma weighted average diluted shares 93.0 Pro forma adjusted EPS $ 1.74 AVNT November Investor Meetings.pdf AVNT Q3 2021 Earnings Presentation.pdf Final 10.27 606pm Q3 21 IR Deck Version v1.pdf

Garratt 3:40 PolyOne Distribution Mark Crist 4:10 Financial Highlights and Goals Bradley C. Patterson President and Chief Executive Officer Bradley C. Garratt President, Performance Products and Solutions PolyOne Corporation Page 48 2014 Revenue by Industry Segment 2014 Revenues: $0.8 Billion At a Glance Performance Products & Solutions 80% 14% Latin America 4% Building & 33% Electrical & 1% 11% 5% Transportation 18% Wire & Cable 16% PolyOne Corporation Page 49 What We Have Delivered 4.3% 6.3% 7.2% 7.7% 2011 2012 2013 2014 Operating Margin $28 $39 $56 $63 2011 2012 2013 2014 Operating Income ($M) •Relentless focus on portfolio mix optimization •Lean Six Sigma drives operational excellence • Innovating in new markets such as healthcare •Expanding presence in Mexico and China Performance Products & Solutions PolyOne Corporation Page 50 $96 $109 2006* 2014 To Value Gross Margin ($ in millions) +13% 1,431 1,124 2006* 2014 From Volume… (lbs in millions) -21% Performance Products & Solutions *2006 = Near peak housing PolyOne Corporation Page 51 Accelerating Growth Market Growth/ Megatrends Innovation Collaboration Geographic Expansion Performance Products & Solutions PolyOne Corporation Page 52 Who We Are Growing With Performance Products & Solutions PolyOne Corporation Page 53 Geographic Growth Opportunities Mexico represents growth, spurred by: • Robust demand in Automotive • Re-shoring from Asia • PolyOne collaboration China is a $2B PVC market; 2nd largest in the world: • A new tax license enables domestic (vs. export) business • We have expanded capacity • We are investing in capability Performance Products & Solutions PolyOne Corporation Page 54 Addressable Market ($ millions) $300 $150 $200 Innovation Pipeline Potential Performance Products & Solutions Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 0 2 0 1 0 3 0 1 1 1 5 3 1 1 1 Breakthrough Platform Derivative PolyOne Corporation Page 55 Megatrends Aligned with Key End Markets Increasing Energy Efficiency Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer Performance Products & Solutions PolyOne Corporation Page 56 Healthcare Solutions LED Lighting Key Initiatives Eco-Conscious Solutions $25M Revenue potential $30M Revenue potential $60M Revenue Potential Performance Products & Solutions PolyOne Corporation Page 57 Platinum Vision 4.3% 6.3% 7.2% 7.7% 10-12% 2011 2012 2013 2014 2020 Platinum Vision World Class Operating Margin Accelerating Growth Performance Products & Solutions Market Growth/ Megatrends Innovation Collaboration Geographic Expansion PolyOne Corporation Page 58 Summary • Business evolution from volume to value • Business is at an inflection point • Growth will be driven by:  Economic & Megatrend alignment  Innovation  Collaboration across PolyOne  Geographic sales expansion in China and Mexico Performance Products & Solutions PolyOne Corporation Page 59 PolyOne Distribution Mark Crist President, Distribution PolyOne Corporation Page 60 At a Glance PolyOne Distribution 15% 52% 2006 2014 Key Suppliers 2014 Revenues: $1.1 Billion ROIC Building & 13% Electrical & 23% 15% 4% 25% http://www.avient.com/Pages/VariationRoot.aspx PolyOne Corporation Page 61 What We Do Processing Expertise World-Class Supply Chain Deep Customer Relationships Market Consultation Right the First Time… Every Time PolyOne Corporation Page 62 What We Have Delivered 2.6% 3.5% 4.6% 6.4% 6.1% 2006 2008 2010 2012 2014 Operating Margin $19 $28 $42 $66 $68 2006 2008 2010 2012 2014 Operating Income ($M) • World class supplier line card • Differentiating with service and operational excellence • Key portfolio additions with DuPont, Bayer and Ineos • Value based selling and discipline PolyOne Distribution PolyOne Corporation Page 63 Accelerating Growth PolyOne Distribution Market Growth/ Megatrends Commercial Investment Cross-Selling & Collaboration Growth in Targeted Areas PolyOne Corporation Page 64 Who We Are Growing With PolyOne Distribution PolyOne Corporation Page 65 Megatrends Aligned with Key End Markets Increasing Energy Efficiency Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Distribution PolyOne Corporation Page 66 Geographic Growth Opportunities • Currently 10% of POD’s revenue is generated from Mexico • Existing business is served “from the border” • New Mexico district & warehouse will drive transportation growth in Central Mexico • Expansion in China resulted from growing with our NA HC customers • Investing in sales deployments • Localizing supply • Gaining Share PolyOne Distribution PolyOne Corporation Page 67 Going Beyond Distribution WeatherTech® – Polymer BumpStep® BEDRUG™ – Tri-fold Truck Bed Cover CeQur PaQ – Type 2 Insulin Delivery Device PolyOne Distribution PolyOne Corporation Page 68 Platinum Vision 2.6% 4.6% 6.1% 6.5 - 7.5% 2006 2010 2014 2020 Platinum Vision World Class Distribution Margin Accelerating Growth PolyOne Distribution Market Growth/ Megatrends Commercial Investment Cross-Selling & Collaboration Growth in Targeted Areas PolyOne Corporation Page 69 Summary • Motivated and well trained POD sellers making the calls / collaborating with other PolyOne businesses • Representing a world class supplier line card • Delighted customers and suppliers who choose us to represent them PolyOne Distribution PolyOne Corporation Page 70 Financial Highlights Bradley C.

DISCLAIMER Avient Corporation 3 Avient Corporation 4 Welcome Chairman, President, and Chief Executive Officer INTRODUCTION Sustainability for a Better Tomorrow Senior Vice President and Chief Financial Officer Avient Corporation 5 WE ARE A FORMULATOR CUSTOM FORMULATION Avient Corporation 6 Avient Corporation 7 WE ARE INNOVATORS 2,500+ ACTIVE PATENT FILINGS WORLDWIDE 1,100+ RESEARCH AND DEVELOPMENT ASSOCIATES >85% Stage-gate technology projects enable sustainable solutions INDIA INNOVATION CENTER 33% 2022 VITALITY INDEX 140+ MATERIAL SCIENCE PhD ASSOCIATES Avient Corporation 8 3% 3% 5% Avient Specialty Formulators Other Specialty / Chemical Companies CAPEX / Revenue 2023E Global footprint enables greater flexibility to exceed needs of customers and deliver localized technical and formulation expertise 9 36 24 Manufacturing Locations by Region WE ARE ASSET LIGHT Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA Avient Corporation 9 Asset-light flexibility enables more nimble manufacturing capabilities and lower overhead Periods of economic weakness have driven higher levels of cash generation due to working capital improvement PROVEN TRACK RECORD OF HIGH FREE CASH FLOW CONVERSION 80% 80% 81% 84% 83% 79% 50% 70% 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023E 150 200 250 300 350 400 Fr ee C as h Fl ow C ve rs io Fr ee C as h Fl ow FCF $ AVNT FCF Conversion % S&P FCF Conversion % 2 Recent Divestitures - Combined $1.7B in Proceeds PORTFOLIO EVOLUTION Avient Corporation 10 Combined $3.6B Investment in Acquisitions Since 2016 Color Business Distribution 2016 2022 PORTFOLIO TRANSFORMATION 46% 87% 0% 20% 2005 2010 2015 2020 2023 % o f A dj us te d EB IT DA Commodity JVs Distribution Performance Products & Solutions Specialty Businesses Adjusted EBITDA from Specialty Applications Avient Corporation 11 END MARKET TRANSFORMATION Defense Avient Corporation 12 8% 23% 4% 2006 2023E Other Industri es 22% 56% 14% 43% 9% 2006 2023E Reduced Exposure to Cyclical End Markets End Market Diversification Transportation Building & Construction 57% Defense IMPROVING PROFITABILITY AND EXPANDING MARGINS Avient Corporation 13 Adj.

Bradley C. s/    Bradley C. s/    Bradley C.

Obtain and review a report from the independent auditor at least annually: (a) regarding the independent auditor’s internal quality-control procedures; (b) regarding any material issues raised by the most recent internal quality-control review, peer review or Public Company Accounting Oversight Board review of the firm, or by any inquiry or investigation by any other governmental or professional authorities within the preceding five years respecting one or more independent audits carried out by the firm; and any steps taken to address any such issues; and (c) to assess the auditor’s independence and all relationships between the independent auditor and the Company. 2.

Tap water was put in a beaker, the top of the beaker was covered with a sample of the test film, and the beaker was put in a refrigerator at 4°C (39°F).

a) 米国食品医薬品局（FDA）または国際標準化機構（ISO）により「インプラント」機器として分類される医療機器、または米国薬局方（USP）または ISO 規格で定義される「パーマネント」 機器、または (b)EU指令90/385/EECの改正で定義された能動埋込型医療機器、または (c)EU指令93/42/EECの改正で定義された「長期」使用のための医療機器。